← Open Payments lookup

PHUONG NGUYEN: Open Payments

NPI 1336505064 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,358 in 156 payments from 13 companies in 2025. Trend: 2023 $48 · 2024 $804 · 2025 $4,358

Food & beverage: $4,248Education: $109
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.24$957
Otsuka America Pharmaceutical, Inc.23$519
Janssen Pharmaceuticals, Inc15$515
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$446
ABBVIE INC.24$379
Vanda Pharmaceuticals Inc.12$338
Alkermes, Inc.14$334
Braeburn Inc.3$278
Neurocrine BioSciences, Inc.5$230
E.R. Squibb & Sons, L.L.C.4$192

Products named: INVEGA SUSTENNA, AUSTEDO XR, CAPLYTA, UZEDY, VRAYLAR, FANAPT, REXULTI, BRIXADI.

Industry payments across PA — which companies pay providers there.